Evidence map›Paper›PMID 29408290›Full record

ArticleClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association2018

Increased Prevalence of Rare Sucrase-isomaltase Pathogenic Variants in Irritable Bowel Syndrome Patients.

Koldo Garcia-Etxebarria, Tenghao Zheng, Ferdinando Bonfiglio, Luis Bujanda, Aldona Dlugosz, Greger Lindberg, Peter T Schmidt, Pontus Karling, Bodil Ohlsson, Magnus Simren and 20 more

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05795049 (Genetic Carbohydrate Maldigestion as a Model to Study Food Hypersensitivity Mechanism and Guide Personalised Treatment Using a Non-invasive Multiparametric Test), which is not on this map. Cited by 46 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 1 pooled it
7.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05795049 active not recruitingnot on this mapstarted 2024, after this paper: background citation

Genetic Carbohydrate Maldigestion as a Model to Study Food Hypersensitivity Mechanism and Guide Personalised Treatment Using a Non-invasive Multiparametric Test (Work Package 1)

TypeobservationalSponsorNottingham University Hospitals NHS TrustRan2024 to 2026Enrolled2,000ConditionsIrritable Bowel Syndrome (IBS), Sucrase Isomaltase DeficiencyArmsStool and saliva sample collection, Questionnaire completion
3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 1 synthesis or guideline pooled it, 90 citations in OpenAlex.

  1. Efficacy of a Restrictive Diet in Irritable Bowel Syndrome: A Systematic Review and Network Meta-analysis.The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi · 2022
    Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Review
  11. Article
  12. [Dietary Therapy in Irritable Bowel Syndrome].The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi · 2025
    Review
  13. Article
  14. Review
  15. Congenital Sucrase-Isomaltase Deficiency: Same Mutation with Different Clinical Presentations.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2024
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 20 institutions in 7 countries.

Koldo Garcia-EtxebarriaDepartment of Gastrointestinal and Liver Diseases, Biodonostia Health Research Institute, San Sebastián, Spain; Unit of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Tenghao ZhengDepartment of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden; Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
Ferdinando BonfiglioDepartment of Gastrointestinal and Liver Diseases, Biodonostia Health Research Institute, San Sebastián, Spain; Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden.
Luis BujandaDepartment of Gastrointestinal and Liver Diseases, Biodonostia Health Research Institute, San Sebastián, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Universidad del País Vasco (UPV/EHU), San Sebastián, Spain.
Aldona DlugoszDepartment of Medicine Solna, Karolinska Institutet, Center for Digestive Diseases, Karolinska University Hospital, Stockholm, Sweden.
Greger LindbergDepartment of Medicine Solna, Karolinska Institutet, Center for Digestive Diseases, Karolinska University Hospital, Stockholm, Sweden.
Peter T SchmidtCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Universidad del País Vasco (UPV/EHU), San Sebastián, Spain.
Pontus KarlingDivision of Medicine, Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
Bodil OhlssonLund University, Skåne University Hospital, Department of Internal Medicine, Lund, Sweden.
Magnus SimrenDepartment of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Susanna WalterDivision of Neuro and Inflammation Science, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
Gerardo NardoneGastroenterology Unit, Department of Clinical Medicine and Surgery, University Federico II, Naples, Italy.
Rosario CuomoDigestive Motility Diseases, Department of Clinical Medicine and Surgery, Federico II University Hospital, Naples, Italy.
Paolo Usai-SattaS.C. Gastroenterologia, Azienda Ospedaliera G. Brotzu, Cagliari, Italy.
Francesca GaleazziUOC Gastroenterologia, Padova University Hospital, Padova, Italy.
Matteo NeriDepartment of Medicine and Aging Sciences and CESI, G. D'Annunzio University and Foundation, Chieti, Italy.
Piero PortincasaDepartment of Biomedical Sciences and Human Oncology (DIMO), Clinica Medica "A. Murri", University of Bari Medical School, Bari, Italy.
Massimo BelliniGastroenterology Unit, Department of Gastroenterology, University of Pisa, Pisa, Italy.
Giovanni BarbaraDepartment of Medical and Surgical Sciences, University of Bologna, St Orsola - Malpighi Hospital, Bologna, Italy.
Daisy JonkersDepartment of Internal Medicine, NUTRIM School for Nutrition and Translational Research in Metabolism, Maastricht University Medical Center+, Maastricht, The Netherlands.
Shanti EswaranDivision of Gastroenterology, University of Michigan, Michigan Medicine, Ann Arbor, Michigan.
William D CheyDivision of Gastroenterology, University of Michigan, Michigan Medicine, Ann Arbor, Michigan.
Purna KashyapDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota.
Lin ChangG. Oppenheimer Center for Neurobiology of Stress and Resilience, Vatche and Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine at UCLA, UCLA, Los Angeles, California.
Emeran A MayerG. Oppenheimer Center for Neurobiology of Stress and Resilience, Vatche and Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine at UCLA, UCLA, Los Angeles, California.
Mira M WoutersTranslational Research Center for Gastro Intestinal Disorders (TARGID), KU Leuven, Leuven, Belgium.
Guy BoeckxstaensTranslational Research Center for Gastro Intestinal Disorders (TARGID), KU Leuven, Leuven, Belgium.
Michael CamilleriClinical Enteric Neuroscience Translational and Epidemiological Research (C.E.N.T.E.R.), and Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, Minnesota.
Andre FrankeInstitute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel, Kiel, Germany.
Mauro D'AmatoDepartment of Gastrointestinal and Liver Diseases, Biodonostia Health Research Institute, San Sebastián, Spain; Unit of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden; IKERBASQUE, Basque Science Foundation, Bilbao, Spain. Electronic address: mauro.damato@ki.se.
Karolinska Institutet · SEFederico II University Hospital · ITKarolinska University Hospital · SEKU Leuven · BEMichigan Medicine · USUniversity of the Basque Country · ESAzienda Ospedaliera G. Brotzu · ITChristian-Albrechts-Universität zu Kiel · DEIkerbasque · ESIRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola · ITLinköping University · SELund University · SEMaastricht University · NLMayo Clinic · USMayo Clinic in Florida · USUmeå University · SEUniversity of Bari Aldo Moro · ITUniversity of Chieti-Pescara · ITUniversity of Gothenburg · SEUniversity of Padua · IT

Funding

PERCEPTION AND MODULATION OF VISCERAL SENSATIONSR01DK048351 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MAYER, EMERAN A · 1996 to 2019
$8.2M
Mechanisms of alteration of GI physiology by gut microbesR01DK114007 · NIDDK · MAYO CLINIC ROCHESTER · PI Purna C Kashyap · 2017 to 2026
$4.7M
NIDDK NIH HHS R01 DK048351NIDDK NIH HHS R01 DK114007
6 · The paper itself

Abstract

Patients with irritable bowel syndrome (IBS) often associate their symptoms to certain foods. In congenital sucrase-isomaltase deficiency (CSID), recessive mutations in the SI gene (coding for the disaccharidase digesting sucrose and 60% of dietary starch)

Indexed as

Gene FrequencyGenotypeHumansIrritable Bowel SyndromePrevalenceSucrase-Isomaltase ComplexSucrase-Isomaltase Complex

Identifiers

PMID29408290
PMCPMC6103908
OpenAlexW2785706387

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.